<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Crystal structures of the CDK5-p25 kinase with bound inhibitors Experiment number: MX-267 MX-394</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2005-07-24">24/07/2005</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Elspeth</forename><surname>Gordon</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology</orgName>
								<orgName type="institution">European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435</addrLine>
									<postCode>20141</postCode>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gavin</forename><surname>Fox</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology</orgName>
								<orgName type="institution">European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435</addrLine>
									<postCode>20141</postCode>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Petra</forename><surname>Pernot</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology</orgName>
								<orgName type="institution">European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435</addrLine>
									<postCode>20141</postCode>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marina</forename><surname>Mapelli</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology</orgName>
								<orgName type="institution">European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435</addrLine>
									<postCode>20141</postCode>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Musacchio</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology</orgName>
								<orgName type="institution">European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435</addrLine>
									<postCode>20141</postCode>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Crystal structures of the CDK5-p25 kinase with bound inhibitors Experiment number: MX-267 MX-394</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2005-07-24">24/07/2005</date>
						</imprint>
					</monogr>
					<idno type="MD5">D1A270897E089522858A465CCB95BCC0</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-22T15:36+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>The cyclin-dependent kinases (CDK) CDK1, CDK2, CDK4, and CDK6 are serine/threonine protein kinases targeted in cancer therapy due to their role in cell cycle progression. The postmitotic CDK5 is involved in biological pathways important for neuronal migration and differentiation. CDK5 represents an attractive pharmacological target as its deregulation is implicated in various neurodegenerative diseases such as Alzheimer's, Parkinson's, and Niemann-Pick type C diseases, ischemia, and amyotrophic lateral sclerosis. We have generated an improved crystal form of CDK5 in complex with p25, a segment of the p35 neuronal activator. The crystals were used to solve the structure of CDK5/p25 with (R)-roscovitine and aloisine at a resolution of 2.2 and 2.3 Ã…, respectively. The structure of CDK5/p25/roscovitine provides a rationale for the preference of CDK5 for the R over the S stereoisomer. Furthermore, roscovitine stabilized an unusual collapsed conformation of the glycine-rich loop, an important site of CDK regulation, and we report an investigation of the effects of glycine-rich loop phosphorylation on roscovitine binding. The CDK5/p25 crystals represent a valuable new tool for the identification and optimization of selective CDK inhibitors.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body/>
		<back>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>from: 28/07/2004 to: 30/07/2004 from: 10/02/2005 to: 11/02/2005 from: 07/05/2005 to: 09/05/2005</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Defining Cdk5 Ligand Chemical Space with Small Molecule Inhibitors of Tau Phosphorylation</title>
		<author>
			<persName><forename type="first">Jae</forename><forename type="middle">Suk</forename><surname>Ahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mala</forename><forename type="middle">L</forename><surname>Radhakrishnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Marina</forename><surname>Mapelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sungwoon</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bruce</forename><surname>Tidor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gregory</forename><forename type="middle">D</forename><surname>Cuny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Andrea</forename><surname>Musacchio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Li-An</forename><surname>Yeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Kenneth</forename><forename type="middle">S</forename><surname>Kosik</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.chembiol.2005.05.011</idno>
	</analytic>
	<monogr>
		<title level="j">Chemistry &amp; Biology</title>
		<title level="j" type="abbrev">Chemistry &amp; Biology</title>
		<idno type="ISSN">1074-5521</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="811" to="823" />
			<date type="published" when="2005-07">2005</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">References: Ahn JS, Radhakrishnan ML, Mapelli M, Choi S, Tidor B, Cuny GD, Musacchio A, Yeh LA, Kosik KS. (2005) Defining Cdk5 Ligand Chemical Space with Small Molecule Inhibitors of Tau Phosphorylation. Chem. Biol. 12, 811-823</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Mechanism of CDK5/p25 Binding by CDK Inhibitors</title>
		<author>
			<persName><forename type="first">Marina</forename><surname>Mapelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lucia</forename><surname>Massimiliano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Claudia</forename><surname>Crovace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Markus</forename><forename type="middle">A</forename><surname>Seeliger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Li-Huei</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Laurent</forename><surname>Meijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Andrea</forename><surname>Musacchio</surname></persName>
		</author>
		<idno type="DOI">10.1021/jm049323m</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Medicinal Chemistry</title>
		<title level="j" type="abbrev">J. Med. Chem.</title>
		<idno type="ISSN">0022-2623</idno>
		<idno type="ISSNe">1520-4804</idno>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="671" to="679" />
			<date type="published" when="2005-01-06">2005</date>
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Mapelli M, Massimiliano L, Crovace C, Seeliger MA, Tsai LH, Meijer L, Musacchio A (2005) Mechanism of CDK5/p25 Binding by CDK Inhibitors. J Med. Chem. 48, 671-679</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
